Statistics for Cisplatin +/− rucaparib after preoperative chemotherapy in patients with triple-negative or BRCA mutated breast cancer
Total visits
| views | |
|---|---|
| Cisplatin +/− rucaparib after preoperative chemotherapy in patients with triple-negative or BRCA mutated breast cancer | 93 |
Total visits per month
| views | |
|---|---|
| December 2023 | 0 |
| January 2024 | 0 |
| February 2024 | 0 |
| March 2024 | 0 |
| April 2024 | 0 |
| May 2024 | 0 |
| June 2024 | 0 |
File Visits
| views | |
|---|---|
| 41523_2021_Article_240.pdf | 46 |
Top country views
| views | |
|---|---|
| United States | 80 |
| China | 1 |
| South Korea | 1 |
| Malaysia | 1 |
| Sweden | 1 |
| Slovenia | 1 |
Top city views
| views | |
|---|---|
| Wilmington | 42 |
| Houston | 11 |
| White Plains | 9 |
| Fairfield | 4 |
| Indianapolis | 2 |
| Ann Arbor | 1 |
| Baltimore | 1 |
| Beijing | 1 |
| Cambridge | 1 |
| Falls Church | 1 |
| Kuala Lumpur | 1 |
| Ljubljana | 1 |
| San Francisco | 1 |
| Seoul | 1 |
| Umeå | 1 |
| Washington | 1 |